Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

Código QR

Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

Aaron C Tan,1 Tracy J Loh,2 Xue Lin Kwang,1 Gek San Tan,2 Kiat Hon Lim,2 Daniel SW Tan1 1Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore; 2Department of Pathology, Singapore General Hospital, Singapore, 169608, SingaporeCorrespondence: Daniel SW TanNation...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tan AC, Loh TJ, Kwang XL, Tan GS, Lim KH, Tan DSW
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	capmatinib met exon 14 skipping non-small cell lung cancer targeted therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/031f63eddb764d4ebbf865c25b2d833d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics
por: Guo MZ, et al.
Publicado: (2021)

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
por: Fujino T, et al.
Publicado: (2021)

Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
por: Franciscus C. Vermeer, et al.
Publicado: (2021)

Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
por: Zhang SS, et al.
Publicado: (2021)

Case Report: A Synonymous Mutation in NF1 Located at the Non-canonical Splicing Site Leading to Exon 45 Skipping
por: Pengzhen Jin, et al.
Publicado: (2021)

Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
por: Stephanie G. Craig, et al.
Publicado: (2021)

Intramuscular Evaluation of Chimeric Locked Nucleic Acid/2′<i>O</i>Methyl-Modified Antisense Oligonucleotides for Targeted Exon 23 Skipping in Mdx Mice
por: Michaella Georgiadou, et al.
Publicado: (2021)

Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer
por: Brazel D, et al.
Publicado: (2021)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Ryota Tanaka, et al.
Publicado: (2021)

Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation
por: Boning Cai, et al.
Publicado: (2021)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang Q, et al.
Publicado: (2020)

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
por: Chung Hyo Kang, et al.
Publicado: (2021)

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
por: Chiara Giacomelli, et al.
Publicado: (2021)

Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report
por: Kato Y, et al.
Publicado: (2021)

Severe Psychiatric Symptoms in a Patient With EGFR Exon-20 Insertion Mutation Receiving Mobocertinib: A Case Report
por: Josette Kamel, BA, et al.
Publicado: (2021)

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients
por: Juliette Palle, et al.
Publicado: (2021)

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Lun-Xi Peng, et al.
Publicado: (2021)

Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
por: Yurong Wang, et al.
Publicado: (2021)

Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion though the MET/AKT/mTOR Axis in Gastric Cancer
por: Juanli Ji, et al.
Publicado: (2021)

Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification
por: Zhu VW, et al.
Publicado: (2019)

Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2
por: Anna Reimer Hansen, et al.
Publicado: (2021)

Short Communication: Polymorphism at third exon of the Myostatin gene and its association with growth and carcass traits in Batur sheep
por: Hassan Ishag Hassan Haren, et al.
Publicado: (2020)

A new solution algorithm for skip-free processes to the left
por: Bauer,Claus
Publicado: (2010)

Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents
por: Han J, et al.
Publicado: (2018)

The risk of lymph node metastasis in gastric cancer conforming to indications of endoscopic resection and pylorus-preserving gastrectomy: a single-center retrospective study
por: Wu Yanzhang, et al.
Publicado: (2021)

Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
por: Editorial team Diabetes Mellitus
Publicado: (2009)

Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer
por: Daniel Martin Klotz, et al.
Publicado: (2021)

Association between XRCC1 exon 10 (Arg399Gln) gene polymorphism and micronucleus as a predictor of DNA damage among radiation workers
por: HARRY NUGROHO EKO SURNIYANTORO, et al.
Publicado: (2018)

E-cadherin and c-Met expression in actinic cheilits and lip squamous cell carcinoma
por: Martínez,A, et al.
Publicado: (2011)

Study of thermal comfort in the City of São Paulo using ENVI-met model
por: Ana Claudia Carfan, et al.
Publicado: (2012)

High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib
por: Zhang Ying, et al.
Publicado: (2021)

Novel Partial Exon 51 Deletion in the Duchenne Muscular Dystrophy Gene Identified via Whole Exome Sequencing and Long-Read Whole-Genome Sequencing
por: Qianqian Li, et al.
Publicado: (2021)

Hydrogen Peroxide Production by <named-content content-type="genus-species">Streptococcus pneumoniae</named-content> Results in Alpha-hemolysis by Oxidation of Oxy-hemoglobin to Met-hemoglobin
por: Erin McDevitt, et al.
Publicado: (2020)

Selenium sulfide disrupts the PLAGL2/C‐MET/STAT3‐induced resistance against mitochondrial apoptosis in hepatocellular carcinoma
por: Tianfeng Yang, et al.
Publicado: (2021)

Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
por: Shankun Zhao, et al.
Publicado: (2021)

Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
por: Thakur MK, et al.
Publicado: (2017)

MET Receptor Tyrosine Kinase Regulates Lifespan Ultrasonic Vocalization and Vagal Motor Neuron Development
por: Anna K. Kamitakahara, et al.
Publicado: (2021)

Very severe spinal muscular atrophy (Type 0)
por: Suleiman Al Dakhoul
Publicado: (2017)

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report
por: Lander Van Acker, et al.
Publicado: (2021)